Life Sciences 2025

CHINA Law and Practice Contributed by: Alan Zhou, Coco Fan, Kelly Cao and Stephanie Wang, Global Law Office

Global Law Office (GLO) has become one of the largest, leading Chinese law firms, with more than 500 lawyers practising in its Bei- jing, Shanghai, Shenzhen and Chengdu of- fices. Its life sciences and healthcare practice group was one of the first in China and provides “one-stop” legal services for every area of the industry, including M&A, investment and fund- ing, licence-in and out, daily operation, IP pro- tection, and advice on compliance, including internal and government investigations as well

as anti-bribery matters and dispute settlement. Under a changing regulatory environment, the firm’s team has the perfect combination of in- ternational experience and local knowledge to support various innovation or pilot projects, in- cluding digital healthcare and MAH/cMAH trial cases. The team participates in the formulation of local codes of conduct and benchmark poli- cies/rules and also co-operates closely with as- sociations such as the CPIA and the RDPAC.

Authors

Alan Zhou is the leading partner of the life sciences and healthcare practice group at Global Law Office and has a strong background in the area, routinely representing

Coco Fan is a partner in the life sciences and healthcare practice group at Global Law Office and specialises in corporate, compliance, private equity, venture capital and M&A.

multinational corporations, well-known Chinese state-owned and private enterprises, and private equity/venture capital funds. As a participant or an external counsel, he has been engaged by local authorities and industrial associations to advise on legislation and industrial standards in the life sciences and healthcare industry, including guidelines on compliance and risk control, e-healthcare, medical insurance reform and medical representative administration. He has been widely published both at home and abroad.

Her experience covers prescription medicine, over-the-counter medicine, contract research organisations, medical devices, biopharmaceuticals, health foods, clinical supply, vaccines, animal health and hospitals. She has advised multinational and private companies and investors on risk assessment, health checks and tailored compliance training, including anti-corruption, antitrust and promotion. She also advises on establishing industrial compliance management standards for pharmaceuticals and medical devices.

65

CHAMBERS.COM

Powered by